The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Trientine 167 mg hard capsules

Tillomed Pharma GmbHPA22720/010/001

Main Information

Trade NameTrientine 167 mg hard capsules
Dosage FormCapsule, hard
Licence HolderTillomed Pharma GmbH
Licence NumberPA22720/010/001

Group Information

ATC CodeA16AX12 Trientine


License statusAuthorised
Licence Issued26/08/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back